COVIDIEN has announced CE Mark approval for its Nellcor Bedside SpO2 patient monitoring system, PM100N. The system provides continuous monitoring of blood oxygenation (SpO2) and pulse rate to help clinicians detect and respond to dangerous respiratory events sooner, along with patient trend data to allow clinicians to evaluate a patient’s clinical course.
The pulse oximetry system has been designed with features to help improve patient safety. It incorporates SatSeconds alarm management technology to help distinguish between serious and minor events, reducing clinically insignificant desaturation alarms. The monitor can also be password-protected to prevent lay users from inadvertently modifying settings.
“Just because a patient is not in the hospital setting does not mean he or she no longer needs on-going care,” said Dr Scott Kelley, chief medical officer, respiratory and monitoring solutions, Covidien. “The availability of solutions to enable safe, quality care for patients in all settings, including the home, is something we are focused on at Covidien.”
